Filing Details
- Accession Number:
- 0001209191-21-067592
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-12-02 16:31:39
- Reporting Period:
- 2021-11-30
- Accepted Time:
- 2021-12-02 16:31:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1347178 | Vanda Pharmaceuticals Inc. | VNDA | Pharmaceutical Preparations (2834) | 030491827 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1355537 | Hristos Mihael Polymeropoulos | 2200 Pennsylvania Avenue Suite 300E Washington DC 20037 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-30 | 78,324 | $4.88 | 1,299,386 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-30 | 50,000 | $16.49 | 1,249,386 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-12-01 | 71,676 | $4.88 | 1,321,062 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-12-01 | 46,200 | $16.00 | 1,274,862 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-11-30 | 78,324 | $0.00 | 78,324 | $4.88 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-12-01 | 71,676 | $0.00 | 71,676 | $4.88 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 71,676 | 2021-12-05 | No | 4 | M | Direct | |
| 0 | 2021-12-05 | No | 4 | M | Direct |
Footnotes
- Represents shares of the Issuer's common stock sold to satisfy the exercise price and certain tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the exercise of certain stock options, which were scheduled to expire December 5, 2021 as reflected in this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.10 to $16.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.70 to $16.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- The option vested in 48 equal monthly installments beginning on January 6, 2012.
Billionaire Hedge Funds
